Objective: To elucidate the effects of sodium butyrate on rat hepatic oval cell differentiation in vitro.

Methods: Hepatic oval cells were isolated from rats fed with a choline-deficient diet supplemented with 0.1% (w/w) ethonine for 4 to 6 weeks. The cultured hepatic oval cells were identified by immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR). After hepatic oval cells were treated with sodium butyrate, the morphological changes were studied through Giemsa staining and the albumin expression level was tested by Western blot.

Results: Immunohistochemical results showed the isolated cells were positive for both mature hepatocyte marker albumin and bile duct cell marker cytokeratin-19. Furthermore, RT-PCR results showed that the cells expressed stem cell marker c-kit, but not hematopoietic stem cell marker CD34. In short, the isolated cells were rat hepatic oval cells. 0.75 mmol/L sodium butyrate induced obvious phenotype changes of hepatic oval cells, including enlargement of the oval cells, a decrease in nucleus to cytoplasm ratio, and a 50% increase in the number of binucleated cells. Western blot results showed that 0.75 mmol/L sodium butyrate markedly raised the expression of albumin.

Conclusion: Sodium butyrate, a differentiation promoting agent, can induce rat hepatic oval cells (liver progenitor cells) to differentiate into mature hepatocytes in vitro.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hepatic oval
32
oval cells
32
sodium butyrate
20
rat hepatic
16
cells
13
cell marker
12
oval
9
hepatic
8
mature hepatocytes
8
isolated cells
8

Similar Publications

Liver regeneration is intricate, involves many cells, and necessitates extended research. This study aimed to investigate the response of liver oval cells (bipotent liver progenitors) to the epigenetic modifier trichostatin A (TSA), an HDAC1 inhibitor, and to develop a scoring system for assessing the response of these cells. Three groups of equally divided rats (n=24) were selected: control (A, dimethyl sulfoxide treated); oval cell induction (B, acetylaminofluorene [2-AAF] to block hepatocyes/carbon tetrachloride [CCL4] to induce oval cell response); and epigenetic modulation (C, TSA post 2-AAF/CCL4 injury).

View Article and Find Full Text PDF

Yiqi Liangxue Jiedu Prescription Inhibited the Canonical Wnt Pathway to Prevent Hepatocellular Precancerous Lesions.

J Hepatocell Carcinoma

November 2024

Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.

Purpose: Yiqi Liangxue Jiedu prescription (YLJP), a Chinese medicine that is commonly used to prevent liver cancer and is authorized by a national patent (patent No. ZL202110889980.5) has a therapeutic effect on precancerous lesions; however, the underlying mechanism remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • - This case report describes a rare instance of metastatic signet ring carcinoma in the ovary of a 46-year-old Black African woman, occurring alongside a benign fibroma, highlighting the complexity of ovarian lesions.
  • - The patient experienced significant abdominal swelling and was found to have a large mass in the right ovary, along with signs of metastasis in the lungs and liver, as indicated by imaging and elevated tumor markers (CA 125 and CA 19-9).
  • - Surgical intervention involved a total abdominal hysterectomy and bilateral salpingo-oophorectomy, revealing a mix of spindle cells and signet ring cells in the ovarian tissues, illustrating the unique histological findings associated with this case.
View Article and Find Full Text PDF
Article Synopsis
  • Primary hepatic neuroendocrine tumors (PHNET) are rare liver tumors, constituting about 0.3% of all neuroendocrine tumors, with symptoms like abdominal pain being more common than diarrhea and flushing.
  • A 50-year-old male patient experienced repeated diarrhea and facial flushing due to PHNET, confirmed through a biopsy and immunohistochemical tests, which showed adenocarcinoma features.
  • The patient underwent transcatheter arterial chemoembolization (TACE) treatment, which successfully alleviated his symptoms, highlighting potential treatment options for this rare disease.
View Article and Find Full Text PDF

Oval cells (OCs) is the name of hepatic progenitor cells (HPCs) in rodents. They are a small population of cells in the liver with the remarkable ability to proliferate and regenerate hepatocytes and cholangiocytes in response to acute liver damage. Isolating OCs generally requires a pretreatment with special diets, chemicals, and/or surgery to induce hepatic damage and OC proliferation in mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!